Free Biochips Journals
Biochips are small specimen trays onto which biological material has been applied for analysis. Biochips also are mentioned as arrays, whereby target molecules* are aligned during a specific order on the chip surface, making it possible to match the results. (*Here the term target molecule is used for
molecules that are bound to the chip surface with a known identity. The free
molecules whose identity is to be determined are referred to as assay molecules). Immobilised spots of under 200-µm diameter are referred to as microarrays; if larger than 300-µm they are called macroarrays. There are now arrays with up to several 100,000 spots on one chip.
Different procedures are used for
biomolecules that are to be immobilised, to bind them to the surface of the biochip. The binding are often an immediate adsorption to the chip surface, or appropriately activated surfaces. Furthermore, special coatings have been developed that enable a maximally reproducible biomolecule binding. These include special hydrophobic coatings and a coating with nitro-cellulose or with special matrices, also utilized in protein clearing.
Biochips for various applications are produced by a corresponding manufacturer and therefore the user carries out the analysis of materials. But now there are complete systems for a biochip assay. Immobilisation of the target molecule on the chip surface is the first fully automated step, then the binding reaction with corresponding
molecules from samples to be analysed and finally the detection and evaluation of the results by using specific software.
High Impact List of Articles
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Slowing progression of idiopathic pulmonary fibrosis with pirfenidone: from clinical trials to real-life experience
Vincent Cottin, M Wijsenbeek, F Bonella & C Vancheri
Review: Clinical Trail Outcomes: Clinical Investigation
-
What does the future hold for uveal melanoma, a historically untreatable disease?
Alexander N Shoushtari , Richard D Carvajal
Editorial: Clinical Investigation
-
What does the future hold for uveal melanoma, a historically untreatable disease?
Alexander N Shoushtari , Richard D Carvajal
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
A vaccine for leukemia: one step closer? Cure-oriented WT1 peptide vaccination therapy is being developed
Yoshihiro Oka
Editorial: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Rationale and methodology for trial-based economic evaluation
Stavros Petrou
Clinical Trail Methodology: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Small sample sizes in clinical trials, a statisticians perspective
Lucinda Billingham, Kinga Malottki,Neil Steven
Editorial: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
-
Therapeutic mesenchymal stem or stromal cells in rheumatic diseases: rationale, clinical data and perspectives
David Guerit, Marie Maumus, Florence Apparailly,Christian Jorgensen,Daniele Noel
Therapeutic Prospective: Clinical Investigation
Relevant Topics in Clinical